Cherkassky, Leonid
Adusumilli, Prasad S.
Article History
First Online: 12 November 2021
Competing interests
: P.S.A. has received research funding from ATARA Biotherapeutics and Acea Biosciences; has served on the scientific advisory boards of, or as a consultant for, ATARA Biotherapeutics, Bayer, Carisma Therapeutics, Imugene, ImmpactBio and Takeda Therapeutics; has pending patent applications on T-cell therapies; and has patents, royalties and intellectual property on mesothelin-targeted CARs and other T-cell therapies and on methods for the detection of cancer cells using viruses. L.C. declares no competing interests.